Table 1.
Baseline characteristics (n = 164)
| N (%) | |
|---|---|
| Characteristic | |
| Total number | 164 (100) |
| Median age (years) and range | 36 (18–87) |
| Males | 98 (59.75) |
| Females | 66 (40.24) |
| Age of AD onset | |
| Lifelong | 158 (93.34) |
| Aged 11 | 1 (0.60) |
| Aged ≥ 30 | 4 (2.43) |
| Hand eczema | 1 (0.60) |
| Comorbidities | |
| Asthma | 91 (55.46) |
| Hay fever/allergic rhinitis | 46 (28.05) |
| Food allergy | 7 (4.27) |
| Chronic urticaria | 2 (1.22) |
| Hypertension | 10 (6.10) |
| T2DM | 4 (2.44) |
| Hyperlipidaemia | 5 (3.05) |
| Alopecia areata | 4 (2.40) |
| HIV | 1 (0.61) |
| Previous treatment | |
| Mean and range | 4.78 (1–9) |
| Ciclosporin | 134 (81.71) |
| Prednisolone | 126 (76.83) |
| Azathioprine | 106 (64.36) |
| Methotrexate | 85 (51.83) |
| Mycophenolate mofetil | 62 (37.80) |
| IM Kenalog | 24 (14.63) |
| TLO1 | 102 (62.20) |
| PUVA | 7 (4.27) |
| Daily dressing | 57 (34.76) |
| Inpatient admissions | 78 (47.56) |
| Othersa | 6 (3.66) |
aOthers: dapsone, alitretinoin, mepolizumab, extracorpeal electrophoresis